Clinical Trial Update: A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004541) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating injections of autologous dermal and epidermal cells for androgenetic alopecia (male and female pattern baldness) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• Autologous dermal and epidermal cell injections

Snippet

Sponsor: Aderans Research Institute | Conditions: Androgenetic Alopecia, Male Pattern Baldness | Phase 2 | Status: COMPLETED